Table 2.

Results of the immunohistochemical analysis of DLBCL




CB, no. (%)

IB, no. (%)

TCRB, no. (%)

All pediatric DLBCL, no. (%)

P
CD10   37 of 46 (80)   2 of 6 (33)   0 of 5 (0)   39 of 57 (68)   ≤ .001  
BCL2   18 of 49 (37)   4 of 6 (67)   ND   22 of 55 (40)   NS  
BCL6   40 of 42 (95)   3 of 5 (60)   4 of 5 (80)   47 of 52 (90)   .029  
Mum-1   17 of 29 (59)   3 of 3 (100)   1 of 3 (33)   21 of 35 (60)   NS  
GCB
 
39 of 44 (87)
 
2 of 5 (40)
 
2 of 3 (67)
 
43 of 52 (83)
 
.02
 



CB, no. (%)

IB, no. (%)

TCRB, no. (%)

All pediatric DLBCL, no. (%)

P
CD10   37 of 46 (80)   2 of 6 (33)   0 of 5 (0)   39 of 57 (68)   ≤ .001  
BCL2   18 of 49 (37)   4 of 6 (67)   ND   22 of 55 (40)   NS  
BCL6   40 of 42 (95)   3 of 5 (60)   4 of 5 (80)   47 of 52 (90)   .029  
Mum-1   17 of 29 (59)   3 of 3 (100)   1 of 3 (33)   21 of 35 (60)   NS  
GCB
 
39 of 44 (87)
 
2 of 5 (40)
 
2 of 3 (67)
 
43 of 52 (83)
 
.02
 

The immunohistochemical results and the classification as GCB subtype are shown in number of positive cases of the evaluable cases (percentage of positive cases) in the morphologic subgroups as well as all DLBCL (χ2 test or Fisher exact test).

ND indicates not done.

or Create an Account

Close Modal
Close Modal